{"id":3323,"date":"2018-11-06T15:54:27","date_gmt":"2018-11-06T14:54:27","guid":{"rendered":"http:\/\/www.sfbmec.fr\/?p=3323"},"modified":"2018-11-06T15:58:57","modified_gmt":"2018-11-06T14:58:57","slug":"ii-joint-meeting-of-dgfl-and-the-italian-society-of-immunology-clinical-immunology-and-allergology-siica-10-13-sept-2019-munchen","status":"publish","type":"post","link":"https:\/\/www.sfbmec.fr\/?p=3323","title":{"rendered":"II Joint Meeting of DGfl and the Italian Society of Immunology, Clinical Immunology and Allergology (SIICA) – 10-13 Sept. 2019 – M\u00fcnchen"},"content":{"rendered":"

\"\"<\/a>II Joint Meeting of DGfl and the Italian Society of Immunology, Clinical Immunology and Allergology (SIICA)
\n<\/strong>10\u201313 September 2019, M\u00fcnchen
\nhttps:\/\/www.immunology-conference.de\/<\/a><\/strong><\/p>\n

\n

Please find below the invitation for the conference chairs (Angela Santori and Thomas Brocker) to attend the IInd Joint Meeting between DGfI<\/a> and the Italian Society of Immunology, Clinical Immunology and Allergology<\/a> (SIICA) that will take place in Munich in September 2019.<\/p>\n

All the relevant information can be found on the website of the conference (immunology-conference.de<\/a>) with the latest version of the preliminary program and flyer for your laboratory.<\/p>\n

\n

Dear colleagues and friends,<\/p>\n

On behalf of the board members of the\u00a0Italian Society for Immunology, Clinical Immunology and Allergology (SIICA)<\/i>\u00a0and the\u00a0German Society for Immunology (DGfI)<\/i>, we are pleased to invite you to our joint annual meeting in Munich running from 10\u201313 September 2019. After a highly successful joint meeting of both societies in Riccione, Italy, in 2011 we are looking forward to seeing you in Munich, the heart of Bavaria, for our next joint meeting.<\/p>\n

Munich is not only a popular tourist destination, but is also the home of two highly renowned German universities, the Ludwig-Maximilians-Universit\u00e4t (LMU) M\u00fcnchen and the Technische Universit\u00e4t M\u00fcnchen (TUM). In addition, the Max Planck Society, the Helmholtz Zentrum M\u00fcnchen and numerous biotech companies and start-ups make Munich a lively environment for basic and translational research in immunology. Scientists in Munich actively participate in a series of immunologically focused Collaborative Research Centres (CRCs) currently funded by the German Research Council (DFG). These include: CRC1054 \u201cPlasticity of immune cell-fate decisions\u201d, CRC914 \u201cTrafficking of immune cells\u201d, CRC1123 \u201cAtherosclerosis\u201d, CRC824 \u201cCancer therapies\u201d, TR36 \u201cT cell therapy\u201d, TRR127 \u201cXenotranplantation\u201d, TR128 \u201cMultiple Sclerosis\u201d and TRR179 \u201dHepatitis-Virus-Infection\u201d.<\/p>\n

The Munich biotech cluster made up of approximately 250 companies, with two innovation and founding centers for biotechnology, demonstrate the important focus our city and region places on personalized medicine and immunotherapy.<\/p>\n

The joint SIICA- and DGfI-meeting in 2019 will take place in the Geschwister-Scholl-Platz historic Hauptgeb\u00e4ude, or main building of the LMU, found in the center of Munich. This location is surrounded by historic buildings, beer gardens, the famous Englischer garten city park, as well as a vibrant city and university life, all well-connected by easily accessible public transportation.<\/p>\n

The organizing committee will strive to bring together an interesting program covering current topics of basic and translational immunological research in plenary sessions, main symposia and workshops. We invite everyone to submit abstracts early in 2019 and to join us in Munich for this exciting meeting.
\nWe are looking forward to welcome you all in this beautiful city.<\/p>\n

Sincerely yours<\/p>\n

Angela Santoni & Thomas Brocker
\nConference chairs<\/p>\n

 <\/p>\n

Partager :<\/h3>